In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...
Novartis will acquire Avidity Biosciences for about US$12 billion to gain its RNA platform and late-stage rare-disease ...
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI ...
In the face of rising costs, food insecurity, and healthcare inequality, the Compassion Center's Coalition for Patient Rights is bringing Las Vegas together for a family-friendly day of food, spirits, ...
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation TherapyBOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana ...
The global digital health market is set to witness a significant growth rate of 20-25% in the next 5 years. increasing adoption of smartphones and wearable devices, rising demand for remote healthcare ...
The large molecule drug substance CDMO market is projected to grow at a CAGR of approximately 9% over the forecast period. This growth is primarily driven by the rising demand for biologics and ...
The Global Advanced Wound Care Market is poised to grow at a CAGR of 6–8% through 2029, driven by the rising incidence of chronic wounds, traumatic and surgical injuries, and a growing elderly ...
ReportALBANY, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third ...
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia ...
The FemTech market is rapidly expanding. As it evolves, FemTech plays a vital role in closing healthcare gaps and advancing personalized, accessible, and data-driven healthcare solutions for women ...
YPrime Launches Advanced eCOA Oversight to Strengthen Investigator Accountability and Participant SafetyNew functionality aligns with EMA, FDA, and ICH E6(R3) expectations for documented investigator ...